# A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545

> **NCT00472758** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 40 (actual)

## Conditions studied

- Chronic Plaque Psoriasis

## Interventions

- **BIOLOGICAL:** MEDI 545
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00472758
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-02
- **Final completion:** 2008-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472758, "A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00472758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*